IDEXX Laboratories, Inc. vs Teucrium Wheat Fund — how do they compare? IDEXX Laboratories, Inc. trades at $551.97 (market cap $44.48B), while Teucrium Wheat Fund trades at $25.11. The key difference: Teucrium Wheat Fund is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | WEAT | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $766.68 | $25.49 |
52-Week Low | $520.87 | $19.88 |
Enterprise Value | $45.38B | — |
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
WEAT trades at $24.99, down 1.03% in the last session, with technical indicators showing a mixed but overall bullish bias. The USDA's reduced 2026 wheat production forecast to 1.56 billion bushels (WSJ, 2026-05-12) and recent wheat price volatility highlight fundamental supply-side influences. Moving averages signal strong bullish momentum, though oscillators indicate near-term overbought conditions.
The outlook for WEAT is cautiously optimistic, driven by agricultural commodity trends and supportive technicals. Key opportunities include exposure to wheat price appreciation, but risks involve weather impacts on crops, inflation fluctuations, and competitive ETF pressure as noted in recent coverage (24/7 Wall Street, 2026-05-16).
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →